HealthQuill India
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More
The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic Survey, a government report, stated.
Drugs Pharma

India’s pharma market to be worth $130 billion by 2030

The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic.

Read More
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL PathLabs, in INR 7.5 million in cash.
Drugs Medical Pharma

Indian diagnostic firm Dr. Lal PathLabs acquires 10% of subsidiary

PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL.

Read More
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose, according to a company statement.
Drugs Medical Pharma

India’s Bharat Biotech rolls out Covid-19 nasal drop vaccine

Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,.

Read More
The WHO called on stakeholders in various nations to take “immediate and coordinated action” to shield children from using contaminated cough syrups following deaths last year.
Drugs Pharma

WHO urges “immediate” action on falsified medicines

The WHO called on stakeholders in various nations to take “immediate and coordinated action” to shield children from using contaminated cough syrups following.

Read More
India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister said.
Drugs Pharma

India bolsters regulators to brace global competition

India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister.

Read More
Adani Renewable Energy Holding Two, a wholly-owned subsidiary of Adani Green Energy, announced it has entered into a binding term sheet to acquire 50% equity in Essel Saurya Urja Company of Rajasthan for INR 150 million.
Climate Health

Adani Green to acquire Essel Saurya in an all-cash deal

Adani Renewable Energy Holding Two, a wholly-owned subsidiary of Adani Green Energy, announced it has entered into a binding term sheet to acquire.

Read More
Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.
Drugs Pharma

Glenmark’s heart failure treatment drug makes India debut

Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.

Read More
The WHO has issued a Medical Product Alert on India’s Marion Biotech’s Ambronol and DOK-1 Max syrups as they failed to meet quality standards.
Drugs Pharma

WHO issues medical product alert on Marion’s syrups

The WHO has issued a Medical Product Alert on India’s Marion Biotech’s Ambronol and DOK-1 Max syrups as they failed to meet quality.

Read More
Merck
Drugs Medical

Fifty million Indians suffer from fungal diseases

More than 50 million Indians suffer from fungal diseases and 10% belong to the potentially dangerous mould infections, according to researchers from New.

Read More